Al-Dawaa Raises Enaya Stake to 63%

The Saudi Pharmaceutical Industries and Medical Supplies Company (Spimaco Pharmaceuticals) increased its stake in Eniya from 51% to 63% through the purchase of a 12% share valued at 45 million riyals from Accelerated Health. This move aims to strengthen its investments in the medical products sector and expand its operations. The financial impact of the deal is expected to begin reflecting in the second half of 2026. In 2025, Eniya achieved revenues of 237 million riyals and profits of 45 million riyals.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل